PE20040466A1 - Triaril-oxi-aril-espiro-pirimidina-2,4,6-triona como inhibidores de metaloproteinasa - Google Patents
Triaril-oxi-aril-espiro-pirimidina-2,4,6-triona como inhibidores de metaloproteinasaInfo
- Publication number
- PE20040466A1 PE20040466A1 PE2003000403A PE2003000403A PE20040466A1 PE 20040466 A1 PE20040466 A1 PE 20040466A1 PE 2003000403 A PE2003000403 A PE 2003000403A PE 2003000403 A PE2003000403 A PE 2003000403A PE 20040466 A1 PE20040466 A1 PE 20040466A1
- Authority
- PE
- Peru
- Prior art keywords
- cr16r17
- cycloalkyl
- aryl
- alkyl
- replaced
- Prior art date
Links
- 239000003112 inhibitor Substances 0.000 title abstract 2
- 150000001875 compounds Chemical class 0.000 abstract 3
- 229910052736 halogen Inorganic materials 0.000 abstract 2
- 150000002367 halogens Chemical class 0.000 abstract 2
- -1 4-FLUOROPHENYL Chemical class 0.000 abstract 1
- 206010028980 Neoplasm Diseases 0.000 abstract 1
- JFDZBHWFFUWGJE-UHFFFAOYSA-N benzonitrile Substances N#CC1=CC=CC=C1 JFDZBHWFFUWGJE-UHFFFAOYSA-N 0.000 abstract 1
- 208000026278 immune system disease Diseases 0.000 abstract 1
- 230000002757 inflammatory effect Effects 0.000 abstract 1
- 239000011159 matrix material Substances 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/10—Spiro-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/06—Anti-spasmodics, e.g. drugs for colics, esophagic dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Pulmonology (AREA)
- Urology & Nephrology (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Heart & Thoracic Surgery (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Ophthalmology & Optometry (AREA)
- Physical Education & Sports Medicine (AREA)
- Cardiology (AREA)
- Dermatology (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Gastroenterology & Hepatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Enzymes And Modification Thereof (AREA)
Abstract
SE REFIERE A UN COMPUESTO DE FORMULA I, DONDE X ES UN ANILLO HETEROCICLICO DE 5 A 7 MIEMBROS CON FORMULA a, b, c, ENTRE OTROS, DONDE CADA LINEA DE TRAZOS REPRESENTA UN DOBLE ENLACE OPCIONAL; A ES ARILO(C6-C10) O HETEROARILO(C1-C10); Y ES UN ENLACE, -O-, -S-, >C=O, >S02, -CH2O-, ENTRE OTROS; B ES ARILO(C6-C10), CICLOALQUILO(C3-C7), HETEROCICLILO(C1-C10) Y HETEROARILO(C1-C10), EN EL QUE 1 O 2 ENLACES C-C DEL CICLOALQUILO O HETEROCICLILO B PUEDEN ESTAR SUSTITUIDOS POR ENLACES C=C; G SE UNE A UN C DEL ANILLO B, EN LA QUE CADA A O B PUEDE ESTAR SUSTITUIDO POR HALOGENO, CN, OH, ALQUILO(C1-C4), PERFLUOROALQUILO(C1-C4), ENTRE OTROS; G ES -[R15-(CR16R17)p]- EN LA QUE EL GRUPO -B-G-W TIENEN LA FORMULA -B-[R15-(CR16R17)p]-W O -B-[(CR16R17)p-R15]-W; p ES DE 0 A 4; W ES ALCOXI(C1-C4), ALQUILO(C1-C4), CICLOALQUILO(C3-C7), ARILO(C6-C10), HETEROARILO(C1-C10) Y HETEROCICLILO(C1-C10) DONDE CADA ANILLO PUEDE ESTAR SUSTITUIDO POR HALOGENO, CN, OH, ALQUILO (C1-C4), ALCOXI(C1-C4), ENTRE OTROS. SON COMPUESTOS PREFERIDOS: 1-(6-{4-[4-(4-FLUOROFENIL)-OXAZOL-2-IL]-FENOXI}-PIRIDIN-3-IL)-1,7,9-TRIAZA-ESPIRO[4,5]DECANO-6,8,10-TRIONA, 4-(2-{4-[5-(6,8,10-TRIOXO-1,7,9-TRIAZA-ESPIRO[4,5]DEC-1-IL)-PIRIDIN-2-ILOXI]-FENIL}-OXAZOL-4-IL)-BENZONITRILO, ENTRE OTROS. TAMBIEN SE REFIERE A UNA COMPOSICION FARMACEUTICA. ESTOS COMPUESTOS SON INHIBIDORES DE METALOPROTEINASAS DE MATRIZ Y SON UTILES EN EL TRATAMIENTO DE TRANSTORNOS DE TEJIDO CONJUNTIVO, INFLAMATORIOS, INMUNOLOGICOS, CANCERES Y OTROS TRANSTORNOS
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US37615702P | 2002-04-26 | 2002-04-26 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PE20040466A1 true PE20040466A1 (es) | 2004-07-24 |
Family
ID=29270770
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PE2003000403A PE20040466A1 (es) | 2002-04-26 | 2003-04-23 | Triaril-oxi-aril-espiro-pirimidina-2,4,6-triona como inhibidores de metaloproteinasa |
Country Status (17)
| Country | Link |
|---|---|
| US (1) | US6916807B2 (es) |
| EP (1) | EP1501834B1 (es) |
| JP (1) | JP2005527598A (es) |
| AR (1) | AR039661A1 (es) |
| AT (1) | ATE304015T1 (es) |
| AU (1) | AU2003219410A1 (es) |
| BR (1) | BR0309281A (es) |
| CA (1) | CA2483075A1 (es) |
| DE (1) | DE60301574T2 (es) |
| ES (1) | ES2247527T3 (es) |
| GT (1) | GT200300097A (es) |
| MX (1) | MXPA04008563A (es) |
| PA (1) | PA8572201A1 (es) |
| PE (1) | PE20040466A1 (es) |
| TW (1) | TW200306833A (es) |
| UY (1) | UY27774A1 (es) |
| WO (1) | WO2003091259A1 (es) |
Families Citing this family (31)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1501833B1 (en) * | 2002-04-26 | 2005-11-02 | Pfizer Products Inc. | N-substituted-heteroaryloxy-aryl-spiro-pyrimidine-2,4,6-trione metalloproteinase inhibitors |
| CA2483075A1 (en) | 2002-04-26 | 2003-11-06 | Pfizer Products Inc. | Triaryl-oxy-aryl-spiro-pyrimidine-2, 4, 6-trione metalloproteinase inhibitors |
| EP1507535A1 (en) | 2002-04-26 | 2005-02-23 | Pfizer Products Inc. | Pyrimidine-2,4,6-trione metallo-proteinase inhibitors |
| NI200300045A (es) | 2002-04-26 | 2005-07-08 | Pfizer Prod Inc | Inhibidores de triariloxiariloxipirimidin-2,4,6-triona de metaloproteinasa. |
| EP1750862B1 (en) | 2004-06-04 | 2011-01-05 | Teva Pharmaceutical Industries Ltd. | Pharmaceutical composition containing irbesartan |
| EP2125750B1 (en) * | 2007-02-26 | 2014-05-21 | Vitae Pharmaceuticals, Inc. | Cyclic urea and carbamate inhibitors of 11beta-hydroxysteroid dehydrogenase 1 |
| WO2009017671A1 (en) * | 2007-07-26 | 2009-02-05 | Vitae Pharmaceuticals, Inc. | Synthesis of inhibitors of 11beta-hydroxysteroid dehydrogenase type 1 |
| AR069207A1 (es) * | 2007-11-07 | 2010-01-06 | Vitae Pharmaceuticals Inc | Ureas ciclicas como inhibidores de la 11 beta - hidroxi-esteroide deshidrogenasa 1 |
| US8440658B2 (en) | 2007-12-11 | 2013-05-14 | Vitae Pharmaceuticals, Inc. | Cyclic urea inhibitors of 11β-hydroxysteroid dehydrogenase 1 |
| TW200934490A (en) * | 2008-01-07 | 2009-08-16 | Vitae Pharmaceuticals Inc | Lactam inhibitors of 11 &abgr;-hydroxysteroid dehydrogenase 1 |
| US8592409B2 (en) * | 2008-01-24 | 2013-11-26 | Vitae Pharmaceuticals, Inc. | Cyclic carbazate and semicarbazide inhibitors of 11β-hydroxysteroid dehydrogenase 1 |
| JP5734666B2 (ja) * | 2008-02-11 | 2015-06-17 | ヴァイティー ファーマシューティカルズ，インコーポレイテッド | １１β−ヒドロキシステロイドデヒドロゲナーゼ１の１，３−オキサアゼパン−２−オン及び１，３−ジアゼパン−２−オン阻害剤 |
| CA2715290A1 (en) * | 2008-02-15 | 2009-08-20 | Vitae Pharmaceuticals, Inc. | Inhibitors of 11beta-hydroxysteroid dehydrogenase 1 |
| WO2009117109A1 (en) * | 2008-03-18 | 2009-09-24 | Vitae Pharmaceuticals, Inc. | Inhibitors of 11beta-hydroxysteroid dehydrogenase type 1 |
| JP5301563B2 (ja) * | 2008-05-01 | 2013-09-25 | ヴァイティー ファーマシューティカルズ，インコーポレイテッド | １１β−ヒドロキシステロイドデヒドロゲナーゼ１の環状インヒビター |
| EP2291371B1 (en) | 2008-05-01 | 2015-06-10 | Vitae Pharmaceuticals, Inc. | Cyclic inhibitors of 11beta-hydroxysteroid dehydrogenase 1 |
| EP2291373B1 (en) * | 2008-05-01 | 2013-09-11 | Vitae Pharmaceuticals, Inc. | Cyclic inhibitors of 11beta-hydroxysteroid dehydrogenase 1 |
| CA2723034A1 (en) | 2008-05-01 | 2009-11-05 | Vitae Pharmaceuticals, Inc. | Cyclic inhibitors of 11beta-hydroxysteroid dehydrogenase 1 |
| CA2729998A1 (en) | 2008-07-25 | 2010-01-28 | Boehringer Ingelheim International Gmbh | Inhibitors of 11beta-hydroxysteroid dehydrogenase 1 |
| PL2324018T3 (pl) | 2008-07-25 | 2014-02-28 | Boehringer Ingelheim Int | Cykliczne inhibitory dehydrogenazy 11 beta-hydroksysteroidowej typu 1 |
| JP5679997B2 (ja) | 2009-02-04 | 2015-03-04 | ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング | １１β−ヒドロキシステロイドデヒドロゲナーゼ１の環状阻害剤 |
| TW201039034A (en) * | 2009-04-27 | 2010-11-01 | Chunghwa Picture Tubes Ltd | Pixel structure and the method of forming the same |
| KR20120061771A (ko) * | 2009-04-30 | 2012-06-13 | 비타이 파마슈티컬즈, 인코포레이티드 | 11베타-하이드록시스테로이드 탈수소효소 1의 고리형 억제제 |
| MA33216B1 (fr) | 2009-04-30 | 2012-04-02 | Boehringer Ingelheim Int | Inhibiteurs cycliques de la 11béta-hydroxysteroïde déshydrogénase 1 |
| WO2011011123A1 (en) | 2009-06-11 | 2011-01-27 | Vitae Pharmaceuticals, Inc. | Cyclic inhibitors of 11beta-hydroxysteroid dehydrogenase 1 based on the 1,3 -oxazinan- 2 -one structure |
| EP2448928B1 (en) | 2009-07-01 | 2014-08-13 | Vitae Pharmaceuticals, Inc. | Cyclic inhibitors of 11beta-hydroxysteroid dehydrogenase 1 |
| US8933072B2 (en) | 2010-06-16 | 2015-01-13 | Vitae Pharmaceuticals, Inc. | Substituted 5-,6- and 7-membered heterocycles, medicaments containing such compounds, and their use |
| EP2585444B1 (en) | 2010-06-25 | 2014-10-22 | Boehringer Ingelheim International GmbH | Azaspirohexanones as inhibitors of 11-beta-hsd1 for the treatment of metabolic disorders |
| WO2012059416A1 (en) | 2010-11-02 | 2012-05-10 | Boehringer Ingelheim International Gmbh | Pharmaceutical combinations for the treatment of metabolic disorders |
| JO3407B1 (ar) | 2012-05-31 | 2019-10-20 | Eisai R&D Man Co Ltd | مركبات رباعي هيدرو بيرازولو بيريميدين |
| AU2019387367A1 (en) | 2018-11-30 | 2021-06-10 | Nuvation Bio Inc. | Diarylhydantoin compounds and methods of use thereof |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US10141A (en) * | 1853-10-18 | Improved life-preserving seat | ||
| US225056A (en) * | 1880-03-02 | Henry humphreville | ||
| US6057A (en) * | 1849-01-23 | Guard or stripper for stirring-machines | ||
| US96803A (en) * | 1869-11-16 | Improvement in machine for bending thills | ||
| US132822A (en) * | 1872-11-05 | Improvement in thrashing-machines | ||
| US5455258A (en) | 1993-01-06 | 1995-10-03 | Ciba-Geigy Corporation | Arylsulfonamido-substituted hydroxamic acids |
| ATE302200T1 (de) | 1997-06-21 | 2005-09-15 | Roche Diagnostics Gmbh | Barbitursaure derivaten mit antimetastatischer und antitumorischer wirkung |
| US6265578B1 (en) | 1999-02-12 | 2001-07-24 | Hoffmann-La Roche Inc. | Pyrimidine-2,4,6-triones |
| PA8498701A1 (es) * | 1999-08-12 | 2002-08-26 | Pfizer Prod Inc | Pirimidina-2,4,6-trionas inhibidores de metaloproteinasas |
| CZ20031083A3 (cs) * | 2000-10-26 | 2004-03-17 | Pfizer Products Inc. | 5-Spiropyrimidin-2, 4, 6-trionové inhibitory metaloproteinasy |
| BR0114917A (pt) | 2000-10-26 | 2003-07-01 | Pfizer Prod Inc | Inibidores de pirimidina-2,4,6-triona metaloproteinase |
| US6841671B2 (en) | 2000-10-26 | 2005-01-11 | Pfizer Inc. | Spiro-pyrimidine-2,4,6-trione metalloproteinase inhibitors |
| EP1501833B1 (en) | 2002-04-26 | 2005-11-02 | Pfizer Products Inc. | N-substituted-heteroaryloxy-aryl-spiro-pyrimidine-2,4,6-trione metalloproteinase inhibitors |
| NI200300045A (es) | 2002-04-26 | 2005-07-08 | Pfizer Prod Inc | Inhibidores de triariloxiariloxipirimidin-2,4,6-triona de metaloproteinasa. |
| CA2483075A1 (en) | 2002-04-26 | 2003-11-06 | Pfizer Products Inc. | Triaryl-oxy-aryl-spiro-pyrimidine-2, 4, 6-trione metalloproteinase inhibitors |
-
2003
- 2003-04-15 CA CA002483075A patent/CA2483075A1/en not_active Abandoned
- 2003-04-15 MX MXPA04008563A patent/MXPA04008563A/es unknown
- 2003-04-15 JP JP2003587817A patent/JP2005527598A/ja active Pending
- 2003-04-15 WO PCT/IB2003/001576 patent/WO2003091259A1/en not_active Ceased
- 2003-04-15 DE DE60301574T patent/DE60301574T2/de not_active Expired - Fee Related
- 2003-04-15 BR BR0309281-0A patent/BR0309281A/pt not_active IP Right Cessation
- 2003-04-15 AT AT03715221T patent/ATE304015T1/de not_active IP Right Cessation
- 2003-04-15 EP EP03715221A patent/EP1501834B1/en not_active Expired - Lifetime
- 2003-04-15 ES ES03715221T patent/ES2247527T3/es not_active Expired - Lifetime
- 2003-04-15 AU AU2003219410A patent/AU2003219410A1/en not_active Abandoned
- 2003-04-21 TW TW092109244A patent/TW200306833A/zh unknown
- 2003-04-23 PE PE2003000403A patent/PE20040466A1/es not_active Application Discontinuation
- 2003-04-23 PA PA20038572201A patent/PA8572201A1/es unknown
- 2003-04-24 UY UY27774A patent/UY27774A1/es not_active Application Discontinuation
- 2003-04-24 AR ARP030101422A patent/AR039661A1/es unknown
- 2003-04-25 US US10/423,671 patent/US6916807B2/en not_active Expired - Fee Related
- 2003-04-25 GT GT200300097A patent/GT200300097A/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| AU2003219410A1 (en) | 2003-11-10 |
| CA2483075A1 (en) | 2003-11-06 |
| WO2003091259A1 (en) | 2003-11-06 |
| ATE304015T1 (de) | 2005-09-15 |
| JP2005527598A (ja) | 2005-09-15 |
| MXPA04008563A (es) | 2004-12-06 |
| PA8572201A1 (es) | 2004-03-10 |
| WO2003091259A8 (en) | 2004-02-12 |
| EP1501834A1 (en) | 2005-02-02 |
| AU2003219410A8 (en) | 2003-11-10 |
| US20030225056A1 (en) | 2003-12-04 |
| UY27774A1 (es) | 2003-11-28 |
| BR0309281A (pt) | 2005-02-22 |
| AR039661A1 (es) | 2005-03-02 |
| GT200300097A (es) | 2004-06-15 |
| DE60301574D1 (de) | 2005-10-13 |
| US6916807B2 (en) | 2005-07-12 |
| TW200306833A (en) | 2003-12-01 |
| DE60301574T2 (de) | 2006-01-12 |
| EP1501834B1 (en) | 2005-09-07 |
| ES2247527T3 (es) | 2006-03-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PE20040466A1 (es) | Triaril-oxi-aril-espiro-pirimidina-2,4,6-triona como inhibidores de metaloproteinasa | |
| PE20050874A1 (es) | Compuestos de bencimidazolona que tienen actividad agonista del receptor 5-ht4 | |
| CY1114662T1 (el) | Ημιφουμαρικο αλας του 1-[4-[1-(4-κυκλοεξυλο-3-τριφθορομεθυλο-βενζυλοξυιμινο)-αιθυλο]-2-αιθυλο-βενζυλο]-αζετιδινο-3-καρβοξυλικου οξεος | |
| MEP53708A (en) | 3-z-[1-(4-(n-((4-methyl-piperazin-1-yl)-methylcarbonyl) -n-methyl -amino) -anilino)-1- phenyl-methylene] -6-methoxycarbonyl -2-indolinone -monoethanesulphonate and the use thereof as a pharmaceutical composition | |
| PE20060427A1 (es) | Derivados de pirazol como inhibidores de la union del glucagon y composiciones | |
| ATE427926T1 (de) | Cycloalkylaminderivate | |
| NO20055680L (no) | Heksahydropyridoisokinoliner som DPP-IV-inhibitorer | |
| AR088808A2 (es) | Derivados de 2h-piridazin-3-ona, composiciones farmaceuticas que los contienen y un proceso para la preparacion de dichos derivados y el uso de dichos derivados para la preparacion de una composicion farmaceutica | |
| ECSP044935A (es) | Inhibidores de la dipeptidil peptidasa beta-amino heterocíclica para el tratamiento o la prevención de la diabetes | |
| CR10027A (es) | Nuevos derivados de pirrol fusionado | |
| CY1106857T1 (el) | Βενζαμιδια 4-(αμινομεθυλ)-πιπεριδινης ως 5ht4-ανταγωνιστες | |
| NO20064599L (no) | Substituerte morfolin- og tiomorfolinderivater | |
| CO5590895A2 (es) | Derivados de sulfonamidas, su preparacion y su aplicacion como medicamentos | |
| UY29389A1 (es) | Derivados sustituidos del ácido1-((4-((((3,3-dimetil-2-oxo-2,3-dihidro-1h-indol-1-il)carbonil)amino)metil)piperidin-1-il)metil)ciclobutanocarboxílico, sales farmaceuticamente aceptables, composiciones que los contienen y aplicaciones. | |
| MX2007000505A (es) | Derivados de oxindol sustituidos y medicamentos que contienen los mismos. | |
| CO5601027A2 (es) | Derivados de imidazol-4-il-etinil-piridina | |
| NO20073287L (no) | 2,5 og 2,6-disubstituerte benzazol-analoger som proteinkinaseinhibitorer | |
| MX2008002061A (es) | Derivados de tiazolil piperidina utiles como moduladores del receptor h3. | |
| PE20070795A1 (es) | Compuestos pirazol-urea-heterociclicos como inhibidores de cinasa | |
| MX2007011695A (es) | Derivados de oxindol sustituido, medicamentos que contienen dichos derivados y uso de los mismos. | |
| NO20081014L (no) | Sammensetninger | |
| NO20082214L (no) | 1,1-Diokso-tiomorfolinyl-indolyl-metanonderivater for anvendelse som H3-modulatorer | |
| PE20070724A1 (es) | Derivados de carbamoilbenzotriazol como inhibidores de lipasas y fosfolipasas | |
| MX2007011698A (es) | Derivados de oxindol sustituido, medicamentos que contienen dichos derivados y uso de los mismos. | |
| ATE449776T1 (de) | Pyrroloä2,3-cüpyridinderivate |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FD | Application declared void or lapsed |